Columbia Financial, Inc.
CLBKNasdaqFinancials · Savings Institution, Federally Chartered · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $51.8M | −$11.7M | $36.1M | $86.2M | $92.0M | $57.6M |
| Total assets | $11.02B | $10.48B | $10.65B | $10.41B | $9.22B | $8.80B |
| Total liabilities | $9.86B | $9.40B | $9.61B | $9.35B | $8.15B | $7.79B |
| Equity | $1.16B | $1.08B | $1.04B | $1.05B | $1.08B | $1.01B |
| EPS (diluted) | $0.51 | $-0.11 | $0.35 | $0.81 | $0.88 | $0.52 |
| Shares out. | 104.7M | 104.9M | 108.0M | 106.7M | 109.7M | 112.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 4.5%
- Return on assets
- 0.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 89.5%
- Debt / equity
- 8.49×
- Book value / share
- $11.08
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −0.2%clean
- Piotroski F-Score
- 6/6mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 2 good- High leverage (liabilities > 70% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Holland Noel R.Director | May 15, 2026 | Grant | 8.708 | $19.57 |
| Kemly Thomas J.Officer — President & CEO | May 15, 2026 | Grant | 94.925 | $19.57 |
| Torres Daria Stacy-WallsDirector | May 15, 2026 | Grant | 249.106 | $19.57 |
| Klimowich JohnOfficer — SEVP & Chief Risk Officer | May 15, 2026 | Grant | 34.983 | $19.57 |
| Prabhu Manesh BalachandranOfficer — EVP & CIO | May 1, 2026 | D | 7,267 | $0.00 |
| Rinaldi Mayra LisethOfficer — EVP, Corp Governance & Culture | May 1, 2026 | D | 6,460 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.6M | 6.8 | +17.7% |
| Apr 30, 2026 | 2.2M | 8.6 | -0.3% |
| Apr 15, 2026 | 2.2M | 10.7 | -0.6% |
| Mar 31, 2026 | 2.2M | 8.2 | +24.9% |
| Mar 13, 2026 | 1.8M | 6.0 | +9.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementMay 15, 2026
- Other material eventMay 11, 2026
- Director / officer changeApr 27, 2026
- Director / officer changeApr 23, 2026
- Results of operationsApr 20, 2026
- Director / officer changeFeb 17, 2026
- Entered a material agreement · Regulation FD disclosureFeb 2, 2026
- Results of operationsFeb 2, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.